To prevent pneumococcal infections, a safer and more effective method nowadays is be vaccinated with pneumococcal vaccines. Currently, 13-valent (for 13 serotypes) and 23-valent (for 23 serotypes) vaccines are more commonly available in the market.
The Scientific Committee on Vaccine Preventable Diseases (SCVPD) of the Centre for Health Protection (CHP) recommends newborns should receive pneumococcal conjugate vaccines (PCV) under the Hong Kong Childhood Immunisation Programme (HKCIP). The standard regimen includes a primary series of 2 doses at 2 and 4 months and a booster dose at 12 months. A single dose of PCV13 catch-up vaccination should be provided to children who have not completed the primary series or received any booster dose of PCV13 between the age of 1 year and under 6 years.
For elderly 65 years of age and older without high-risk conditions*, SCVPD recommends either a single dose of PCV13 or a single dose of 23vPPV.
*High-risk conditions include:
a. History of invasive pneumococcal disease;
b. Immunocompromised states:
- Asplenia, HIV /AIDS , primary immunodeficiency
- Immunodeficiencies related to malignancies and transplantation
- Immunodeficiencies related to use of immunosuppressive drugs / systemic steroid
c. Chronic disease
- Chronic cardiac, pulmonary, liver or renal disease
- Diabetes mellitus or cerebrospinal fluid leakage
d. With cochlear implants
(Essential hypertension per se is not considered as a high-risk condition)
Patients with high-risk conditions should consult their doctors before receiving pneumococcal vaccine.